Forum for Science, Industry and Business
  • Sponsored by:
  • Siemens
  • Siemens
  • Siemens
Search our Site:

Topic (optional):

 

Home Reports Health and Medicine Content

Tuberculosis drug combined with virtual reality therapy is effective in treating fear of heights

next article
08.11.2004

 


A tuberculosis drug called D-cycloserine (DCS), used in concert with psychotherapy, is an effective treatment for some anxiety-related disorders, according to research by scientists at Emory University School of Medicine and the Center for Behavioral Neuroscience (CBN). The study was led by Michael Davis, PhD, Kerry Ressler, MD, PhD, and Barbara Rothbaum, PhD, of the Department of Psychiatry and Behavioral Sciences and is reported in the November issue of the Archives of General Psychiatry.

In the study of 28 people suffering from acrophobia, which is an abnormal fear of heights, either DCS or placebo was given to study participants, followed by two virtual reality sessions that simulated standing in a rising glass elevator. Compared to subjects who took only placebo, those treated with DCS experienced a significant reduction in their fear of heights that was maintained for at least three months (the longest time tested) after concluding therapy.


The mechanisms governing the fear response, located in a region of the brain called the amygdala, function abnormally in an acrophobic’s brain. DCS binds to neurotransmitter receptors in the amygdala called NMDA (N-methyl-D-aspartate) receptors. When combined with virtual reality exposure therapy, DCS facilitates fear extinction in the acrophobic’s brain. "Cognitive behavioral psychotherapy uses a process called ’fear extinction’ to treat individuals with phobias, as well as more complicated problems, such as post-traumatic stress syndrome," said Dr. Davis.

"Fear extinction involves repeated exposure to a fearful memory or object, in the absence of adverse consequences. Because it was known that DCS improves NMDA synaptic transmission and we found it improved extinction in rats, we hoped to facilitate the effects of cognitive behavioral therapy by combining DCS with virtual reality therapy in humans. Our results demonstrate that this combination is effective, and that these effects can be long lasting."

Kathi Baker | Source: EurekAlert!
Further information: www.emory.edu

next article

More articles from Health and Medicine:

nachricht Colonial Urbanization in Africa at Dawn of 20th Century Marked Outbreak of HIV
02.10.2008 | University of Arizona

nachricht Brain Signal Persists Even in Dreamless Sleep
02.10.2008 | Washington University in St. Louis

B2B Search

Product / Service
Company / Organisation

Latest News

Cells that Avoid Suicide May Become Cancerous

02.10.2008 | Life Sciences

VTT, Turku University Hospital and Gothenburg University studying how gut microbes affect on progression of type 1 diabetes

02.10.2008 | Life Sciences

New species thanks to different ways of seeing

02.10.2008 | Life Sciences